Drugs & Therapy Perspectives

, Volume 19, Issue 2, pp 22–25 | Cite as

Effective Risk Management is the Key to Maximising the Benefits of Self Medication

Practical Issues and Updates
  • 24 Downloads

Keywords

Terfenadine Astemizole Levonorgestrel Adverse Drug Reaction Reporting Multifaceted Approach 

References

  1. 1.
    Hughes CM, McElnay JC, Fleming GF. Benefits and risks of self medication. Drug Safety 2001; 24 (14): 1027–37PubMedCrossRefGoogle Scholar
  2. 2.
    Segall A. A community survey of self-medication activities. Med Care 1990; 28: 301–10PubMedCrossRefGoogle Scholar
  3. 3.
    Wearn A, Gill P, Gray M, et al. Pharmacists’ views on deregulating emergency hormonal contraception. Pharm J 2001; 266: 89–92Google Scholar
  4. 4.
    Blenkinsopp A, Bradley C. Patients, society, and the increase in self-medication. BMJ 1996; 312: 629–32PubMedCrossRefGoogle Scholar
  5. 5.
    Soller RW. OTCS 2000: achievements and challenges. Drug Info J 2000; 34: 693–701CrossRefGoogle Scholar
  6. 6.
    Powis MG, Rogers PJ, Wood SM. United Kingdom community pharmacists’ views on recent ‘POM’ to ‘P’ switched medicines. J Soc Admin Pharm 1996; 13: 188–97Google Scholar
  7. 7.
    Erwin J, Britten N, Jones, R. General practitioners’ views on over the counter sales by community pharmacists. BMJ 1996; 312: 617–8PubMedCrossRefGoogle Scholar
  8. 8.
    Sihvo S, Hemminki E, Ahonen R. Physicians’ attitudes towards reclassifying drugs as over-the-counter. Med Care 1999; 37: 518–25PubMedCrossRefGoogle Scholar
  9. 9.
    Tasch RF, Goeree R, Henke CJ, et al. Switching the histamine H2-receptor antagonist famotidine to nonprescription status in Canada. Pharmacoeconomics 1996; 9: 61–75PubMedCrossRefGoogle Scholar
  10. 10.
    Stearns SC, Bernard SL, Fasick SB, et al. The economic implications of self-care: the effect of lifestyle, functional adaptations and medical self-care among a national sample of Medicare beneficiaries. Am J Public Health 2000; 90: 1608–12PubMedCrossRefGoogle Scholar
  11. 11.
    Ferris DG, Dekle C, Kitaker MS. Women’s use of over-the-counter antifungal medications for gynaecological symptoms. J Fam Pract 1996; 42: 595–600PubMedGoogle Scholar
  12. 12.
    Anderson M, Schou JS. Safety implications of over-the-counter availability of H2-antagonists. Drug Saf 1993; 8: 179–85CrossRefGoogle Scholar
  13. 13.
    Holt GA, Hall EL. The self-care movement. In: American Pharmaceutical Association/The National Professional Society of Pharmacists. Handbook of nonprescription drugs. 9th ed. Washington, DC: American Pharmaceutical Society 1990: 1–10Google Scholar
  14. 14.
    Chrischilles EA, Lemke JH, Wallace RB. Prevalence and characteristics of multiple analgesic drug use in an elderly patient study group. J Am Geriatr Soc 1990; 38: 979–84PubMedGoogle Scholar
  15. 15.
    Kogan MD, Pappas G, Yu SM, et al. Over-the-counter medication use among US preschool-age children. JAMA 1994; 272: 1025–30PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 2003

Personalised recommendations